Iryna Pishel
Research Subjects
Iryna Pishel has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Pavel K. Mykhailiuk
Enamine Ltd Kyiv Ukraine
9 shared publications - Vladimir Kubyshkin
Enamine Ltd., Winston Churchill Street 78, 02094 Kyiv, Ukraine
5 shared publications Daniil Vysochyn
Enamine Ltd., Kyiv, Ukraine
3 shared publications- Petro Borysko
Enamine Ltd Kyiv Ukraine
3 shared publications - Alexander A. Kirichok
Enamine (Ukraine)
2 shared publications Andrei A. Tolmachev
Enamine Ltd, Kyiv, Ukraine
2 shared publications
Latest Publications
- Open Access
- 28 November 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Replacement of a piperidine ring with aza-spirocycles reduces cardiotoxicity of a local anesthetic
Bupivacaine, a sodium ion channel inhibitor, has a long history of clinical use in local anesthesia and pain management. However, its systemic toxicity, which can lead to adverse cardiac conditions, poses a significant challenge in clinics. In this study, we replaced the central piperidine ring of bupivacaine with three linear spirocyclic moieties and evaluated the effects of the resulting analogues using physicochemical tests and animal studies. We found that, despite being more hydrophobic than the parent drug, the analogues demonstrated an acceptable level of local anesthesia in mice. Notably, the spirocyclic structures exhibited significantly lower toxicity, with increases in the lethal doses of 1.3-, 2.2-, and 5.0-fold for the three tested structures, respectively. Animal studies suggested that this reduced toxicity may be attributed to lower cardiotoxicity, as evidenced by less QRS widening in isolated guinea pig hearts. Our results suggest that further exploration of spirocyclic analogues of local anesthetics is warranted and support the use of spirocyclic azetidines as a replacement for the piperidine ring in drugs.
- 28 November 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessReplacement of a piperidine ring with aza-spirocycles reduces cardiotoxicity of a local anesthetic
Bupivacaine, a sodium ion channel inhibitor, has a long history of clinical use in local anesthesia and pain management. However, its systemic toxicity, which can lead to adverse cardiac conditions, poses a significant challenge in clinics. In this study, we replaced the central piperidine ring of bupivacaine with three linear spirocyclic moieties and evaluated the effects of the resulting analogues using physicochemical tests and animal studies. We found that, despite being more hydrophobic than the parent drug, the analogues demonstrated an acceptable level of local anesthesia in mice. Notably, the spirocyclic structures exhibited significantly lower toxicity, with increases in the lethal doses of 1.3-, 2.2-, and 5.0-fold for the three tested structures, respectively. Animal studies suggested that this reduced toxicity may be attributed to lower cardiotoxicity, as evidenced by less QRS widening in isolated guinea pig hearts. Our results suggest that further exploration of spirocyclic analogues of local anesthetics is warranted and support the use of spirocyclic azetidines as a replacement for the piperidine ring in drugs.
- Open Access
- 29 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-10
A reagent to access methyl sulfones
A chemical reagent to access methyl sulfones has been developed. Its reaction with various bis-nucleophiles leads to the rapid formation of previously unknown heteroaromatic methyl sulfones. Analogous strategy can also be used to construct alkyl-, CHF2-, CF3- and even bicyclo[1.1.1]pentane-containing derivatives. These compounds have been demonstrated to have a high potential for use in medicinal chemistry and coordination chemistry.
- 29 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-10
Open AccessA reagent to access methyl sulfones
A chemical reagent to access methyl sulfones has been developed. Its reaction with various bis-nucleophiles leads to the rapid formation of previously unknown heteroaromatic methyl sulfones. Analogous strategy can also be used to construct alkyl-, CHF2-, CF3- and even bicyclo[1.1.1]pentane-containing derivatives. These compounds have been demonstrated to have a high potential for use in medicinal chemistry and coordination chemistry.
- Open Access
- 5 September 2024
- Published by Springer Nature in Nature Synthesis
- Vol. 3 (12) , 1538-1549
Light-enabled scalable synthesis of bicyclo[1.1.1]pentane halides and their functionalizations
In 2012, bicyclo[1.1.1]pentanes were demonstrated to be bioisosteres of the benzene ring. Here, we report a general scalable reaction between alkyl iodides and propellane that provides bicyclo[1.1.1]pentane iodides in milligram, gram and even kilogram quantities. The reaction is performed in flow and requires just light; no catalysts, initiators or additives are needed. The reaction is clean enough that, in many cases, evaporation of the reaction mixture provides products in around 90% purity that can be directly used in further transformations without any purification. Combined with the subsequent functionalization, >300 bicyclo[1.1.1]pentanes for medicinal chemistry have been prepared. So far, this is the most general and scalable approach towards functionalized bicyclo[1.1.1]pentanes.
- 5 September 2024
- Published by Springer Nature in Nature Synthesis
- Vol. 3 (12) , 1538-1549
Open AccessLight-enabled scalable synthesis of bicyclo[1.1.1]pentane halides and their functionalizations
In 2012, bicyclo[1.1.1]pentanes were demonstrated to be bioisosteres of the benzene ring. Here, we report a general scalable reaction between alkyl iodides and propellane that provides bicyclo[1.1.1]pentane iodides in milligram, gram and even kilogram quantities. The reaction is performed in flow and requires just light; no catalysts, initiators or additives are needed. The reaction is clean enough that, in many cases, evaporation of the reaction mixture provides products in around 90% purity that can be directly used in further transformations without any purification. Combined with the subsequent functionalization, >300 bicyclo[1.1.1]pentanes for medicinal chemistry have been prepared. So far, this is the most general and scalable approach towards functionalized bicyclo[1.1.1]pentanes.
- Open Access
- 22 January 2024
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (9) , e202316557
Spiro[3.3]heptane as a Saturated Benzene Bioisostere**
The spiro[3.3]heptane core, with the non‐coplanar exit vectors, was shown to be a saturated benzene bioisostere. This scaffold was incorporated into the anticancer drug sonidegib (instead of the meta‐benzene), the anticancer drug vorinostat (instead of the phenyl ring), and the anesthetic drug benzocaine (instead of the para‐benzene). The patent‐free saturated analogs obtained showed a high potency in the corresponding biological assays.
- 22 January 2024
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (9) , e202316557
Open AccessSpiro[3.3]heptane as a Saturated Benzene Bioisostere**
The spiro[3.3]heptane core, with the non‐coplanar exit vectors, was shown to be a saturated benzene bioisostere. This scaffold was incorporated into the anticancer drug sonidegib (instead of the meta‐benzene), the anticancer drug vorinostat (instead of the phenyl ring), and the anesthetic drug benzocaine (instead of the para‐benzene). The patent‐free saturated analogs obtained showed a high potency in the corresponding biological assays.
- Open Access
- 2 November 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Spiro[3.3]heptane as a Non-collinear Benzene Bioisostere
Spiro[3.3]heptane can mimic the mono-, meta- and para-substituted phenyl rings in drugs.
- 2 November 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessSpiro[3.3]heptane as a Non-collinear Benzene Bioisostere
Spiro[3.3]heptane can mimic the mono-, meta- and para-substituted phenyl rings in drugs.
- Open Access
- 31 August 2023
- Published by Open Exploration Publishing in Exploration of Immunology
- Vol. 3 (4) , 325-340
Immune system rejuvenation—approaches and real achievements
Interest in the mechanisms of aging of the immune system has not faded over the past 100 years, and it is caused by the immune-mediated development of age-related pathology, including autoimmune organ damage, reduced vaccination efficiency, atherosclerosis, the development of cardiovascular pathology, etc. In contrast to many other organs and systems, the immune system aging begins at an early age and has more pronounced changes that lead to the development of secondary pathology, which significantly affects life expectancy. But an effective strategy to restore immune function has not been developed yet. During this time, the mechanisms of age-related dysfunction of organs and cells of both the adaptive and innate immune systems were studied in detail—thymus involution, a decrease in the potential of hematopoietic stem cells, impaired differentiation and functions of immunocompetent cells, as well as the ways of their interaction. Numerous potential therapeutic targets have been identified and various approaches have been used to implement such therapeutic interventions. The review is devoted to replacement therapy using transplantation of hematopoietic stem cells (HSCs) and young lymphoid cells and tissues, cellular and systemic factor exchange in heterochronic parabiosis, and some other widely used life extension approaches. It has been proven that cell therapy using young cells to rejuvenate the old immune system, unfortunately, often turns out to be ineffective because it does not eliminate the root cause of age-related changes. The phenomenon of inflamm-aging that develops with age can significantly affect both the aging of the organism in general and the functioning of immunocompetent cells in particular. Therefore, the most promising direction in the restoration of immune functions during aging is systemic approaches that have a complex effect on the organism as a whole and can slow down the aging process.
- 31 August 2023
- Published by Open Exploration Publishing in Exploration of Immunology
- Vol. 3 (4) , 325-340
Open AccessImmune system rejuvenation—approaches and real achievements
Interest in the mechanisms of aging of the immune system has not faded over the past 100 years, and it is caused by the immune-mediated development of age-related pathology, including autoimmune organ damage, reduced vaccination efficiency, atherosclerosis, the development of cardiovascular pathology, etc. In contrast to many other organs and systems, the immune system aging begins at an early age and has more pronounced changes that lead to the development of secondary pathology, which significantly affects life expectancy. But an effective strategy to restore immune function has not been developed yet. During this time, the mechanisms of age-related dysfunction of organs and cells of both the adaptive and innate immune systems were studied in detail—thymus involution, a decrease in the potential of hematopoietic stem cells, impaired differentiation and functions of immunocompetent cells, as well as the ways of their interaction. Numerous potential therapeutic targets have been identified and various approaches have been used to implement such therapeutic interventions. The review is devoted to replacement therapy using transplantation of hematopoietic stem cells (HSCs) and young lymphoid cells and tissues, cellular and systemic factor exchange in heterochronic parabiosis, and some other widely used life extension approaches. It has been proven that cell therapy using young cells to rejuvenate the old immune system, unfortunately, often turns out to be ineffective because it does not eliminate the root cause of age-related changes. The phenomenon of inflamm-aging that develops with age can significantly affect both the aging of the organism in general and the functioning of immunocompetent cells in particular. Therefore, the most promising direction in the restoration of immune functions during aging is systemic approaches that have a complex effect on the organism as a whole and can slow down the aging process.
- Open Access
- 27 June 2023
- Published by American Chemical Society (ACS) in ChemRxiv
The LARGEST library of Bicyclo[1.1.1]pentanes for Drug Discovery enabled by Light
In 2012, bicyclo[1.1.1]pentanes were demonstrated to be bioisosteres of the phenyl ring. Today, after more than a decade, the difficulty in their large-scale preparation is still a problem, that often outweighs the corresponding derivatives to becoming clinical candidates. Here, we report a practical general reaction that gives bicyclo[1.1.1]pentanes on mg- to kg-quantities using just light. No additional additives or catalysts are needed. Using this strategy, we have prepared >300 functionalized bicyclo[1.1.1]pentanes on a (multi)gram scale. So far, this is the most general and practical approach to bicyclo[1.1.1]pentanes. Many of these molecules, which were previously commercialized, are already being used in drug discovery by pharmaceutical companies Gilead Sciences, Hoffman-La Roche, Idorsia, Merck, Janssen Pharm., etc. This work should ease the transition of bicyclo[1.1.1]pentane-containing bioactive compounds to clinical candidates, and subsequently to drugs.
- 27 June 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessThe LARGEST library of Bicyclo[1.1.1]pentanes for Drug Discovery enabled by Light
In 2012, bicyclo[1.1.1]pentanes were demonstrated to be bioisosteres of the phenyl ring. Today, after more than a decade, the difficulty in their large-scale preparation is still a problem, that often outweighs the corresponding derivatives to becoming clinical candidates. Here, we report a practical general reaction that gives bicyclo[1.1.1]pentanes on mg- to kg-quantities using just light. No additional additives or catalysts are needed. Using this strategy, we have prepared >300 functionalized bicyclo[1.1.1]pentanes on a (multi)gram scale. So far, this is the most general and practical approach to bicyclo[1.1.1]pentanes. Many of these molecules, which were previously commercialized, are already being used in drug discovery by pharmaceutical companies Gilead Sciences, Hoffman-La Roche, Idorsia, Merck, Janssen Pharm., etc. This work should ease the transition of bicyclo[1.1.1]pentane-containing bioactive compounds to clinical candidates, and subsequently to drugs.
- Open Access
- 12 April 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Bicyclic Bioisosteres of Piperidine: Version 2.0
1-Azaspiro[3.3]heptanes were synthesized, characterized, and validated biologically in vivo as a new generation of saturated piperidine bioisosteres.
- 12 April 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessBicyclic Bioisosteres of Piperidine: Version 2.0
1-Azaspiro[3.3]heptanes were synthesized, characterized, and validated biologically in vivo as a new generation of saturated piperidine bioisosteres.
- Open Access
- 27 July 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 12 (34) , 11294-11305
Oxa-spirocycles: synthesis, properties and applications
A general approach to a new generation of spirocyclic molecules – oxa-spirocycles – was developed. The key synthetic step was iodocyclization. More than 150 oxa-spirocyclic compounds were prepared. Incorporation of an oxygen atom into the spirocyclic unit dramatically improved water solubility (by up to 40 times) and lowered lipophilicity. More potent oxa-spirocyclic analogues of antihypertensive drug terazosin were synthesized and studied in vivo.
- 27 July 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 12 (34) , 11294-11305
Open AccessOxa-spirocycles: synthesis, properties and applications
A general approach to a new generation of spirocyclic molecules – oxa-spirocycles – was developed. The key synthetic step was iodocyclization. More than 150 oxa-spirocyclic compounds were prepared. Incorporation of an oxygen atom into the spirocyclic unit dramatically improved water solubility (by up to 40 times) and lowered lipophilicity. More potent oxa-spirocyclic analogues of antihypertensive drug terazosin were synthesized and studied in vivo.
- 15 February 2018
- Published by Wiley in Chemistry – A European Journal
- Vol. 24 (21) , 5444-5449
Synthesis of Multifunctional Spirocyclic Azetidines and Their Application in Drug Discovery
The synthesis of multifunctional spirocycles was achieved from common cyclic carboxylic acids (cyclobutane carboxylate, cyclopentane carboxylate, l‐proline, etc.). The whole sequence included only two chemical steps—synthesis of azetidinones, and reduction into azetidines. The obtained spirocyclic amino acids were incorporated into a structure of the known anesthetic drug Bupivacaine. The obtained analogues were more active and less toxic than the original drug. We believe that this discovery will lead to a wide use of spirocyclic building blocks in drug discovery in the near future.
- 15 February 2018
- Published by Wiley in Chemistry – A European Journal
- Vol. 24 (21) , 5444-5449
Synthesis of Multifunctional Spirocyclic Azetidines and Their Application in Drug Discovery
The synthesis of multifunctional spirocycles was achieved from common cyclic carboxylic acids (cyclobutane carboxylate, cyclopentane carboxylate, l‐proline, etc.). The whole sequence included only two chemical steps—synthesis of azetidinones, and reduction into azetidines. The obtained spirocyclic amino acids were incorporated into a structure of the known anesthetic drug Bupivacaine. The obtained analogues were more active and less toxic than the original drug. We believe that this discovery will lead to a wide use of spirocyclic building blocks in drug discovery in the near future.